bibliographic resource 2213766 [br/2213766]
https://w3id.org/oc/corpus/br/2213766
- is a
-
- title
-
- Phase IIB Trial of Oral Midostaurin (PKC412), the FMS-Like Tyrosine Kinase 3 Receptor (FLT3) and Multi-Targeted Kinase Inhibitor, in Patients With Acute Myeloid Leukemia and High-Risk Myelodysplastic Syndrome With Either Wild-Type or Mutated FLT3
- publication date
-
- contributor
-
- format
-
- identifier
-
- part of
-